Swedish Orphan Biovitrum retained earnings (accumulated deficit) for the quarter ending September 30, 2024 were $1.970B, a 22.83% increase year-over-year.
Swedish Orphan Biovitrum retained earnings (accumulated deficit) for 2023 were $1.703B, a 8.79% increase from 2022.
Swedish Orphan Biovitrum retained earnings (accumulated deficit) for 2022 were $1.565B, a 2.03% increase from 2021.
Swedish Orphan Biovitrum retained earnings (accumulated deficit) for 2021 were $1.534B, a 34.32% increase from 2020.
Swedish Orphan Biovitrum Retained Earnings (Accumulated Deficit) 2019-2024 | BIOVF